![]() |
![]() |
Legal status
Patent lapsed (non-payment of fees)
(51) | INT.CL. | C07D 471/04 | (2006.01) |
A61K 31/437 | (2006.01) | ||
A61K 35/00 | (2006.01) |
(11) | Number of the document | 2576546 |
(13) | Kind of document | T |
(96) | European patent application number | 10784398.9 |
Date of filing the European patent application | 2010-11-22 | |
(97) | Date of publication of the European application | 2013-04-10 |
(45) | Date of publication and mention of the grant of the patent | 2015-07-22 |
(46) | Date of publication of the claims translation | 2015-09-25 |
(86) | Number | PCT/US2010/057587 |
Date | 2010-11-22 |
(87) | Number | WO 2011/149492 |
Date | 2011-12-01 |
(30) | Number | Date | Country code |
787682 | 2010-05-26 | US |
(72) |
BRUNCKO, Milan, US
DING, Hong, US
DOHERTY, George, US
ELMORE, Steven, US
HASVOLD, Lisa, US
HEXAMER, Laura, US
KUNZER, Aaron R., US
SONG, Xiaohong, US
SOUERS, Andrew, J., US
SULLIVAN, Gerard, US
TAO, Zhi-Fu, US
WANG, Gary, T., US
WANG, Le, US
WANG, Xilu, US
WENDT, Michael, US
MANTEI, Robert, US
HANSEN, Todd, M., US
|
(73) |
AbbVie Bahamas Ltd.,
Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau,
BS
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Apoptozę sukeliantys agentai, skirti vėžio ir imuninių bei autoimuninių ligų gydymui |
APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES |
Payment date | Validity (years) | Amount | |
2020-11-12 | 11 | 289.00 EUR |
Patent lapsed (non-payment of fees) | ||
Invalidation date | 2021-11-22 |